Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT / C. Koenecke, D. Eikema, S. Hazelaar, T. Schroeder, V. Potter, N. Kröger, M. Bornhäuser, J. Finke, U. Platzbecker, A. Radujkovic, A. Ganser, U. Salmenniem, D. Blaise, G. Kobbe, E. Meijer, L. Friis, J. Maertens, D. Caballero, J.J. Cornelissen, A. Olivieri, O. Gulsum, P.J. Hayden, F. Onida, M. Robin, I. Yakoub-Agha. - In: BONE MARROW TRANSPLANTATION. - ISSN 0268-3369. - 57:10(2022), pp. 1607-1611. [10.1038/s41409-022-01759-7]
Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT
F. Onida;
2022
| File | Dimensione | Formato | |
|---|---|---|---|
|
Prognostic value of CPSS cytogenetic risk classification in CMML after alloSCT - BMT 2022.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
720.78 kB
Formato
Adobe PDF
|
720.78 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
